Membrane is a winner in the Innovation, Research & Development, and Environmental categories in the 2025 Pharmaceutical ...

Zambon Pharma has received approval from Chinese regulatory authorities and launched Fluimucil (N-acetylcysteine).

Navamedic has signed an agreement for the acquisition of Norwegian company dne pharma in a deal valued at Nkr225m ($22m).

The FDA's new genAI-assisted scientific review technology, named Elsa, was officially adopted by the agency on 2 June.

Novo Nordisk has ended a partnership with telehealth company Him & Hers, after launching the collaboration less than two ...

Harbour BioMed has entered a strategic partnership with Otsuka focusing on the development of HBM7020 for treating autoimmune ...

An EMA committee has recommended approval of Alvotech’s AVT06, a biosimilar to Bayer’s blockbuster ophthalmology drug Eylea.

Revenue for Madrigal’s Rezdiffra, already approved in the US, is expected to skyrocket over the coming decade.

Dedicated datasets highlight how social determinants of health can be used to improve overall standards of care.

While the outlook for vaccines in the US looks bleak under Trump's administration, the UK is pressing ahead with securing its ...

Shares in both companies were down following news of the second death, casting fresh safety concerns over Elevidys.